Recombinant multi-species CXCL8/IL-8/IL8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL8/IL-8/IL8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]
The Alternative Names of target: C-X-C motif chemokine 8,CXCL8,Chemokine (C-X-C motif) ligand 8,Emoctakin,GCP-1,GCP1,Granulocyte chemotactic protein 1 (GCP-1),IL-8,IL8,Interleukin-8,LECT,LUCT,LYNAP,MDNCF,MONAP,Monocyte-derived neutrophil chemotactic factor (MDNCF),Monocyte-derived neutrophil-activating peptide (MONAP),NAF,NAP-1,NAP1,Neutrophil-activating protein 1 (NAP-1),Protein 3-10C,SCYB8,T-cell chemotactic factor
Go
to CXCL8/IL-8/IL8 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T22658-Ag-1/ GM-Tg-hg-T22658-Ag-2 | Human CXCL8/IL-8/IL8 protein | Human |
GM-Tg-rg-T22658-Ag-1/ GM-Tg-rg-T22658-Ag-2 | Rat CXCL8/IL-8/IL8 protein | Rat |
GM-Tg-mg-T22658-Ag-1/ GM-Tg-mg-T22658-Ag-2 | Mouse CXCL8/IL-8/IL8 protein | Mouse |
GM-Tg-cynog-T22658-Ag-1/ GM-Tg-cynog-T22658-Ag-2 | Cynomolgus/Rhesus macaque CXCL8/IL-8/IL8 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T22658-Ag-1/ GM-Tg-felg-T22658-Ag-2 | Feline CXCL8/IL-8/IL8 protein | Feline |
GM-Tg-cang-T22658-Ag-1/ GM-Tg-cang-T22658-Ag-2 | Canine CXCL8/IL-8/IL8 protein | Canine |
GM-Tg-bovg-T22658-Ag-1/ GM-Tg-bovg-T22658-Ag-2 | Bovine CXCL8/IL-8/IL8 protein | Bovine |
GM-Tg-equg-T22658-Ag-1/ GM-Tg-equg-T22658-Ag-2 | Equine CXCL8/IL-8/IL8 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T22658-Ag-1/ GM-Tg-hg-T22658-Ag-2;
GM-Tg-rg-T22658-Ag-1/ GM-Tg-rg-T22658-Ag-2;
GM-Tg-mg-T22658-Ag-1/ GM-Tg-mg-T22658-Ag-2; GM-Tg-cynog-T22658-Ag-1/ GM-Tg-cynog-T22658-Ag-2; GM-Tg-felg-T22658-Ag-1/ GM-Tg-felg-T22658-Ag-2; GM-Tg-cang-T22658-Ag-1/ GM-Tg-cang-T22658-Ag-2; GM-Tg-bovg-T22658-Ag-1/ GM-Tg-bovg-T22658-Ag-2; GM-Tg-equg-T22658-Ag-1/ GM-Tg-equg-T22658-Ag-2 |
Products Name | CXCL8/IL-8/IL8 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | CXCL8/IL-8/IL8 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL8/IL-8/IL8 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.